化痰活血扶正方及其拆方后的相关药组对模型大鼠肝纤维化指标的影响

表2 各药组对肝纤维化大鼠模型LN、COL₄、HA的影响 (n = 8)

分组	LN	COL4	HA
Contrl	659.4 ± 87.34	314.8 ± 24.21	10.2 ± 0.79
Model	1021.6 ± 68.75a	400.8 ± 58.07a	13.8 ± 1.36a
Silybin	587.8 ± 44.10e	420.0 ± 31.40	11.0 ± 1.77
HTL	778.1 ± 123.46d	328.9 ± 53.50	12.8 ± 0.65
HTM	817.9 ± 93.64c	312.3 ± 63.74c	12.7 ± 1.78
HTH	630.1 ± 50.82e	353.3 ± 47.93	12.4 ± 1.75
HXHYL	818.7 ± 61.19c	282.0 ± 27.33e	13.2 ± 2.22
HXHYM	887.6 ± 94.67	348.7 ± 47.40	11.6 ± 1.01c
HXHYH	754.4 ± 114.4d	350.1 ± 57.72	11.7 ± 1.08
FZL	837.0 ± 103.79c	336.0 ± 42.03	11.7 ± 1.51c
FZM	838.2 ± 142.65	314.3 ± 59.28c	12.0 ± 1.11
FZH	695.7 ± 70.64e	344.6 ± 50.74	11.6 ± 1.07
HTHXFZL	801.3 ± 123.81c	274.4 ± 47.09e	12.2 ± 1.42
HTHXFZ	502.4 ± 122.0e	246.9 ± 22.2e	12.4 ± 1.05
M	720.6 ± 136.14e	252.9 ± 30.8e	11.4 ± 0.89d
HTHXFZH

^aP<0.05与正常组比较;

^cP<0.05,

^dP<0.01,

^eP<0.001与模型组比较. LN: 层黏连蛋白; COL₄: Ⅳ型胶原蛋白; HA: 透明质酸酶.